Literature DB >> 7803225

Changing the risk spectrum of injury and the performance of sunscreen products throughout the day.

R M Sayre1, N Kollias, R D Ley, A H Baqer.   

Abstract

Sunscreen products are tested normally against a defined solar simulator spectrum that, in ultraviolet (UVB), closely resembles the noontime spectral composition of summer sunlight. Although such a spectrum may define the product for use in the most adverse sunlight conditions, little attention has been given to how such products perform against other natural sunlight spectra. Outdoor clinical trials suggest that indoor testing of sunscreens may overestimate the performance of many products. In this study we compared the predicted efficacy of specific products to a variety of natural sunlight spectra taken at different solar angles and under different atmospheric conditions. We found that a standard product always provides less protection for a natural sunlight spectrum than its label value would suggest. The deviation from the labeled value is the greatest when the sun is low in the sky, i.e., close to the horizon. The deviation is due to the changing ratio of UVA to UVB radiation in natural sunlight. The deviation can be as large as a factor of 2.0.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803225

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN: 0905-4383            Impact factor:   3.135


  2 in total

1.  Evaluation of a Sunscreen Product Compared with Reference Standards P3, P5 and P8 in Outdoor Conditions: a Randomized, Double-Blinded, Intra-individual Study in Healthy Subjects.

Authors:  Corinne Granger; Gitanjali Petkar; Muzzammil Hosenally; Javier Bustos; Carles Trullàs; Thierry Passeron; Jean Krutmann
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-29

2.  Outdoor sunscreen testing with high-intensity solar exposure in a Chinese and Caucasian population.

Authors:  Corinne Granger; Gavin Ong; Philippe Andres; Carles Trullàs; Muzzammil Hosenally; Wei Lai; Wei Liu; Jean Krutmann; Thierry Passeron; Henry W Lim
Journal:  Photodermatol Photoimmunol Photomed       Date:  2021-08-04       Impact factor: 3.254

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.